Stocktoria
ARTIVION, INC. AORT
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1993-02-12
ARTIVION, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $441.3M | $388.5M | $354.0M | $313.8M | $298.8M |
| Gross profit | $284.2M | $248.8M | $229.2M | $202.5M | $197.5M |
| R&D expense | $31.0M | $28.5M | $28.7M | $38.9M | $35.5M |
| SG&A expense | $226.5M | $181.5M | $209.0M | $157.4M | $169.8M |
| Operating income | $33.7M | $38.9M | $5.7M | $6.2M | $8.1M |
| Interest expense | — | — | $25.3M | $18.2M | $16.9M |
| Income tax | $5.0M | $5.8M | $9.1M | $4.2M | $7,000 |
| Net income | $9.8M | -$13.4M | -$30.7M | -$19.2M | -$14.8M |
| EPS (diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
| Operating cash flow | $39.9M | $22.2M | $18.8M | -$5.2M | -$2.6M |
| Free cash flow | $839,000 | $11.0M | $9.1M | -$15.9M | -$15.7M |
| Cash & equivalents | $64.9M | $53.5M | $58.9M | $39.4M | $55.0M |
| Inventory | $92.4M | $79.8M | $82.0M | $74.5M | $77.0M |
| Total assets | $884.8M | $789.1M | $792.4M | $762.8M | $793.1M |
| Total liabilities | $436.6M | $512.9M | $510.6M | $478.5M | $492.3M |
| Shareholders' equity | $448.2M | $276.2M | $281.8M | $284.3M | $300.7M |
Source: SEC EDGAR filings · CIK 0000784199 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.